Development and dissemination of education materials on rare disease drug development
Ended Awarded Last action
- Contract number
- 75F40122F19011
- Awardee
-
Booz Allen Hamilton Inc. UEI JCBMLGPE6Z71 Part of Booz Allen Hamilton Holding Corporation
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,846,441
Award facts
- Contract value 100% obligated
- $1,846,441.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $184,935 | |
| Funding Only Action | $690,840 | |
| Original award | $970,666 |
About this award
This is a contract awarded by the Food and Drug Administration (FDA) to Booz Allen Hamilton Inc., a prominent management, technology, and engineering services firm. The contract is for the development and dissemination of educational materials on rare disease drug development. The contract was awarded on August 22, 2022, with a ceiling value of $1,846,441.05. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed-price pricing type. The period of performance has been extended by 4 months, with additional deliverables added within the existing scope of work, and additional project management hours to support the project. The contract does not have a set-aside designation. Booz Allen Hamilton Holding Corporation is the parent company of the prime contractor, Booz Allen Hamilton Inc. This contract leverages Booz Allen Hamilton's extensive experience in providing professional services, including IT infrastructure support, cybersecurity, and strategic consulting, to various federal agencies.
Quick answers
Who was awarded contract 75F40122F19011?
75F40122F19011 was awarded to Booz Allen Hamilton Inc. by Food and Drug Administration (Department of Health and Human Services) on August 22, 2022.
How much is contract 75F40122F19011 worth?
The government has obligated $1,846,441 on 75F40122F19011.
Is contract 75F40122F19011 an order under another contract?
Yes. 75F40122F19011 is a BPA call under GS00F008DA-75F40122A00008, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40122F19011 competed?
The extent of competition for 75F40122F19011 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award